Viridian Therapeutics, Inc.\DE

NEW YORK STATE COMMON RETIREMENT FUND VRDN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

30,720

Value ($000)

956

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	956	0.0%	30,720	12/31/2025
2025 Q3	11/3/2025	426	0.0%	19,719	9/30/2025
2025 Q2	10/8/2025	276	0.0%	19,719	6/30/2025
2025 Q1	10/8/2025	266	0.0%	19,719	3/31/2025
2024 Q4	10/8/2025	378	0.0%	19,719	12/31/2024
2024 Q3	10/8/2025	449	0.0%	19,719	9/30/2024
2024 Q2	10/8/2025	257	0.0%	19,719	6/30/2024
2024 Q1	10/8/2025	314	0.0%	17,946	3/31/2024
2023 Q4	10/8/2025	378	0.0%	17,495	12/31/2023
2023 Q3	10/8/2025	236	0.0%	15,950	9/30/2023
2023 Q2	10/8/2025	376	0.0%	15,795	6/30/2023
2023 Q1	10/8/2025	513	0.0%	19,928	3/31/2023
2022 Q4	10/8/2025	666	0.0%	22,820	12/31/2022
2022 Q3	11/8/2022	363	0.0%	18,016	9/30/2022
2022 Q2	8/4/2022	206	0.0%	17,800	6/30/2022